Literature DB >> 30191016

Aggressive systemic mastocytosis of the liver with cholangitis.

Nina Waldburger1,1, Christian Rupp2,2, Sabine Klinke2,2, Kathrin Wieczorek1,1, Daniel Gotthardt2,2, Thomas Kirchner3,3, Peter Schirmacher1,1, Beate Katharina Straub1,1.   

Abstract

Mastocytosis is a clonal, neoplastic mast cell proliferation, which is in most cases restricted to the skin (cutaneous mastocytosis), but may infiltrate other organs as well (systemic mastocytosis). Involvement of the liver by a systemic mastocytosis with impairment of liver function has been recognized as sign of an aggressive course of disease (C-finding). This article presents a case of aggressive systemic mastocytosis in a 26-year-old male patient with involvement of the liver mimicking primary sclerosing cholangitis. By histology we could demonstrate multifocal clusters of atypical mast cells infiltrating portal tracts in intimate contact with bile ducts as the cause of cholangitis and liver fibrosis.

Entities:  

Keywords:  liver; mastocytosis; primary sclerosing cholangitis

Year:  2015        PMID: 30191016      PMCID: PMC6095320          DOI: 10.2217/hep.15.33

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  19 in total

Review 1.  The liver, spleen, and lymph nodes in mastocytosis.

Authors:  D D Metcalfe
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

2.  A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.

Authors:  Leona A Doyle; Golrokh J Sepehr; Matthew J Hamilton; Cem Akin; Mariana C Castells; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

Review 3.  Intrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature.

Authors:  E L Safyan; M P Veerabagu; S H Swerdlow; R G Lee; J Rakela
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

4.  Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis--report of four cases.

Authors:  D Kyriakou; E Kouroumalis; J Konsolas; H Oekonomaki; M Tzardi; P Kanavaros; O Manoussos; G D Eliopoulos
Journal:  Am J Gastroenterol       Date:  1998-01       Impact factor: 10.864

5.  Cholestatic jaundice and bone lesions in an elderly woman.

Authors:  Georgios I Papachristou; Anthony J Demetris; Fiona Craig; Kenneth K W Lee; Mordechai Rabinovitz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-11

Review 6.  Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.

Authors:  Bryan Hennessy; Francis Giles; Jorge Cortes; Susan O'brien; Alessandra Ferrajoli; Gladys Ossa; Guillermo Garcia-Manero; Stefan Faderl; Hagop Kantarjian; Srdan Verstovsek
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

Review 7.  Aggressive systemic mastocytosis presenting with hepatic cholestasis.

Authors:  Sonia S Kupfer; John Hart; Smruti R Mohanty
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-10       Impact factor: 2.566

8.  New aspects of liver abnormalities as part of the systemic mast cell activation syndrome.

Authors:  Kirsten Alfter; Ivar von Kügelgen; Britta Haenisch; Thomas Frieling; Alexandra Hülsdonk; Ulrike Haars; Arndt Rolfs; Gerhard Noe; Ulrich W Kolck; Jürgen Homann; Gerhard J Molderings
Journal:  Liver Int       Date:  2008-07-23       Impact factor: 5.828

9.  Aggressive systemic mastocytosis mimicking sclerosing cholangitis.

Authors:  Laura Marbello; Michela Anghilieri; Annamaria Nosari; Ernesto Minola; Roberto Cairoli; Francesca Ricci; Enrica Morra
Journal:  Haematologica       Date:  2004-09       Impact factor: 9.941

Review 10.  Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.

Authors:  Celalettin Ustun; David L DeRemer; Cem Akin
Journal:  Leuk Res       Date:  2011-06-08       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.